Hematological malignancies are cancers that originate in the blood-forming and lymphatic tissues, including the leukemias, lymphomas, and plasma-cell disorders such as myeloma. They arise from the abnormal proliferation of hematopoietic or lymphoid cells in the bone marrow, blood, or lymphoid organs, and they requir…
Hematological malignancies are cancers that originate in the blood-forming and lymphatic tissues, including the leukemias, lymphomas, and plasma-cell disorders such as myeloma. They arise from the abnormal proliferation of hematopoietic or lymphoid cells in the bone marrow, blood, or lymphoid organs, and they require specialized diagnosis, classification, and treatment within the overlapping disciplines of hematology and oncology. Their study spans molecular mechanisms, diagnostic markers, complications, and therapeutic and transplantation strategies. The articles gathered here reflect this scope across several blood cancers. Lymphoma is well represented, including work on lactate dehydrogenase as a marker of disease growth in childhood lymphoma, a case of nodular lymphocyte-predominant Hodgkin lymphoma complicated by hormonal disturbance, and characterization of an older oncology population. Leukemogenesis and cellular markers feature in study of neuropilin expression in leukemia development and in cholesterol-conjugated siRNA distribution among hematopoietic and lymphoid cells. Coagulation and supportive-care complications appear in work on acquired abnormalities of von Willebrand factor and ADAMTS13 in aggressive malignancies and on stem-cell mobilization. Infectious complications of treatment are addressed through itraconazole prophylaxis for invasive aspergillosis in a hematology ward. Together these contributions illustrate the central concerns of the field: understanding the biology of malignant blood and lymphoid cells, refining diagnosis and prognostic markers, and managing the treatment and complications of hematological cancers.
10 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The 10 articles above have been cited 30 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
A sample of recent works citing this journal's research on Oncology Hematological Malignancies, linking to each citing work.